Tiyani E Mabunda1, Nalezani J Ramalivhana2, Yoswa M Dambisya3. 1. Limpopo Provincial Department of Health, Polokwane 0700; South Africa. 2. Department of Public Health, University of Limpopo, Sovenga 0727, South Africa. 3. Department of Pharmacy, University of Limpopo, Sovenga 0727, South Africa.
Abstract
BACKGROUND: South Africa has a high tuberculosis burden, and Limpopo Province experienced higher than national average TB mortality rates between 1997 and 2008. OBJECTIVE: To establish factors associated with TB mortality in Limpopo Province in 2008. DESIGN: Retrospective study using provincial data for patients who died after commencing TB treatment between 01 January 2008 and 31 December 2008. RESULTS: In 2008, some 18074 patients started treatment: 15995 (88.5%) had pulmonsry TB (PTB), while 2079 (11.5%) had Extra pulmonary TB (EPTB). Overall, 2242 (12.4%) patients died, mainly PTB patients (n=1906; 85%), more males (n=1159, 51.7%), mainly those aged 25 to 54 years (n=1749, 78.0%), and new cases (1914; 85.4%). TB mortality was significantly higher among smear negative than smear positive patients (17% vs 13.8%; P<0.001), among those with EPTB compared to PTB patients (P<0.001), and among re-treatment cases (P<0.001). Only 4237 (23.4%) patients had HIV status known, with higher mortality found among HIV positive than the HIV negative patients (P<0.0001); but HIV status was not known for the majority who died (n=1685, 75.2%). CONCLUSION: Higher mortality was associated with age 22-55 years; smear negativity, EPTB, HIV infection, and re-treatment. The findings call for greater integration of TB control efforts and HIV services, especially among the 22-55 year age group.
BACKGROUND: South Africa has a high tuberculosis burden, and Limpopo Province experienced higher than national average TB mortality rates between 1997 and 2008. OBJECTIVE: To establish factors associated with TB mortality in Limpopo Province in 2008. DESIGN: Retrospective study using provincial data for patients who died after commencing TB treatment between 01 January 2008 and 31 December 2008. RESULTS: In 2008, some 18074 patients started treatment: 15995 (88.5%) had pulmonsry TB (PTB), while 2079 (11.5%) had Extra pulmonary TB (EPTB). Overall, 2242 (12.4%) patients died, mainly PTBpatients (n=1906; 85%), more males (n=1159, 51.7%), mainly those aged 25 to 54 years (n=1749, 78.0%), and new cases (1914; 85.4%). TB mortality was significantly higher among smear negative than smear positive patients (17% vs 13.8%; P<0.001), among those with EPTB compared to PTBpatients (P<0.001), and among re-treatment cases (P<0.001). Only 4237 (23.4%) patients had HIV status known, with higher mortality found among HIV positive than the HIV negative patients (P<0.0001); but HIV status was not known for the majority who died (n=1685, 75.2%). CONCLUSION: Higher mortality was associated with age 22-55 years; smear negativity, EPTB, HIV infection, and re-treatment. The findings call for greater integration of TB control efforts and HIV services, especially among the 22-55 year age group.
Authors: Stephanus Komati; Pamela A Shaw; Nomso Stubbs; Monkwe J Mathibedi; Lizette Malan; Phumelele Sangweni; Julia A Metcalf; Henry Masur; Shaheen Hassim Journal: AIDS Date: 2010-07-31 Impact factor: 4.177
Authors: C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner Journal: AIDS Date: 2000-06-16 Impact factor: 4.177
Authors: Y S Schreiber; A F Herrera; D Wilson; K Wallengren; R Draper; J Muller; H Dawood; S Doucette; D W Cameron; G G Alvarez Journal: Int J Tuberc Lung Dis Date: 2009-10 Impact factor: 2.373
Authors: Edward C Jones-López; Irene Ayakaka; Jonathan Levin; Nancy Reilly; Francis Mumbowa; Scott Dryden-Peterson; Grace Nyakoojo; Kevin Fennelly; Beth Temple; Susan Nakubulwa; Moses L Joloba; Alphonse Okwera; Kathleen D Eisenach; Ruth McNerney; Alison M Elliott; Jerrold J Ellner; Peter G Smith; Roy D Mugerwa Journal: PLoS Med Date: 2011-03-15 Impact factor: 11.069
Authors: Ingrid V Bassett; Sharon M Coleman; Janet Giddy; Laura M Bogart; Christine E Chaisson; Douglas Ross; Moses J E Flash; Tessa Govender; Rochelle P Walensky; Kenneth A Freedberg; Elena Losina Journal: J Acquir Immune Defic Syndr Date: 2017-04-01 Impact factor: 3.731
Authors: Kudakwashe C Takarinda; Charles Sandy; Nyasha Masuka; Patrick Hazangwe; Regis C Choto; Tsitsi Mutasa-Apollo; Brilliant Nkomo; Edwin Sibanda; Owen Mugurungi; Anthony D Harries; Nicholas Siziba Journal: Tuberc Res Treat Date: 2017-03-02